Company · CIK 0000901832 · SIC 2834 — Pharmaceutical Preparations · NYSE

ASTRAZENECA PLC · AZN

Insider activity reported against this company. All insider holders · Files at: PHAS, ETTX, ALBO. On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market activity at this companybuys $3,249 · 1sales $0 · 0net $3,249

Open-market trades as an insider elsewherebuys $6.7M · 2sales $10.7M · 1net −$4.0M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Sep 8, 2026 AForm 4 →	Sep 11, 4:05 pm EDT	Mani SharmaSee Remarks	1	$162.60	$163	19,289	—	late
Aug 8, 2026 PForm 4 →	Sep 11, 4:05 pm EDT	Mani SharmaSee Remarks	20	$160.57	$3,249	19,288	+0.11%	late
Aug 6, 2026 AForm 4 →	Aug 7, 11:40 am EDT	Mani SharmaSVP, Group Controller	2	$163.34	$327	19,267	—
Jul 6, 2026 AForm 4 →	Jul 8, 4:30 pm EDT	Mani SharmaSee Remarks	2	$190.43	$381	19,265	—
Jun 8, 2026 AForm 4 →	Jun 16, 4:05 pm EDT	Mani SharmaSee Remarks	1	$179.75	$180	19,263	—	late

No reported derivative activity in this period.

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Oct 22, 2018 PForm 4 →	Oct 24, 4:16 pm EDT	PhaseBio Pharmaceuticals IncPHAS	600,000	$5.00	$3,000,000	3,004,554	+25.0%	plan?
Oct 22, 2018 CForm 4 →	Oct 24, 4:16 pm EDT	PhaseBio Pharmaceuticals IncPHAS	2,404,554	—	—	2,404,554	—	plan?
Sep 28, 2018 PForm 4 →	Oct 2, 9:35 pm EDT	Entasis Therapeutics Holdings Inc.ETTX	246,666	$15.00	$3,699,990	2,164,855	+12.9%	plan?
Sep 28, 2018 CForm 4 →	Oct 2, 9:35 pm EDT	Entasis Therapeutics Holdings Inc.ETTX	1,918,185	—	—	1,918,189	—	plan?
Dec 1, 2017 SForm 4 →	Dec 5, 4:18 pm EST	ALBIREO PHARMA, INC.ALBO	500,000	$21.40	$10,700,000	508,141	−49.6%	plan?

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Oct 22, 2018 CSXForm 4 →	Oct 24, 4:16 pm EDT	PhaseBio Pharmaceuticals IncPHAS	2,635,070	$0.2344	$27,337	0	—
Sep 28, 2018 CForm 4 →	Oct 2, 9:35 pm EDT	Entasis Therapeutics Holdings Inc.ETTX	33,499,900	—	—	0	—